Ultragenyx Pharmaceutical

16 Decision Makers Β· 19 Verified Contacts & Email Format

πŸ“ Novato, California, United StatesBiotechnologyπŸ—“ Est. 2010πŸ‘₯ 501–1000 employees

About Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Email Format

{first_letter_first_name}{last_name}@ultragenyx.com β€” 83.3%

ssmith@ultragenyx.com

{first_name}@ultragenyx.com β€” 16.7%

sarah@ultragenyx.com

Leadership & Decision Makers

Contact details of 16 Ultragenyx Pharmaceutical decision makers

John Klock

Founder
  • Work email

    j**n@ultragenyx.com

Jung Cho

Associate Director of Validation LinkedIn
  • Work email

    j**o@ultragenyx.com

Akhilesh Bhambhani

Sr. Director, Biologics Drug Product Development- Tech Dev/Tech Ops LinkedIn
  • Work email

    a********i@ultragenyx.com

Marisa Capponi

Associate Director LinkedIn
  • Work email

    m******i@ultragenyx.com

Benjamin Ehrhart

Vice President, Assistant General Counsel LinkedIn
  • Work email

    b******t@ultragenyx.com

Kenneth Lowe

Director

Howard Horn

Executive Vice President and CFO

John Pinion

EVP Translational Sciences, Chief Quality Operations Officer

Carolyn Wang

SVP, Global Corporate Communications

Dennis Huang

Chief Technical Operations Officer; EVP Gene Therapy Operations

Emil D. Kakkis

Founder

Devan Krishnamoorthi

CIO & Senior Vice President

Kathleen McKeever

Senior Vice President

Arjun Natesan

Senior Vice President

Binodh DeSilva

Senior Vice President

Wenchi Liu

Senior Vice President, Legal

Team & Specialists

Contact details of 3 Ultragenyx Pharmaceutical team members

Xiaohui Lu

Senior Research Scientist
  • Work email

    x*u@ultragenyx.com

Yael Weiss

VP Business Development,Executive Director, Search and Evaluation, Business Development

Christine Murray

Senior Advisor, Development

General Emails

General company emails, e.g. customer support lines

    info@ultragenyx.com

    General Inquiries

    trialrecruitment@ultragenyx.com

    Unclassified inbox

    MCorley@ultragenyx.com

    Unclassified inbox

    higair@ultragenyx.com

    Investor Relations

    blakemedia@ultragenyx.com

    Media Relations

    ekakkis@ultragenyx.com

    Unclassified inbox

    gcapiaux@ultragenyx.com

    Unclassified inbox

    mwhetstone@ultragenyx.com

    Unclassified inbox

Similar Companies like Ultragenyx Pharmaceutical

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology Β· Palo Alto, CA Β· Est. 2003 Β· 501–1000 employees Β· $500M–$1B

HQ: Palo Alto, CA

Moderna

modernatx.com
Biotechnology Β· Cambridge, MA Β· Est. 2010 Β· 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology Β· Bothell, Washington, United States Β· Est. 1998 Β· 1001–5000 employees Β· $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology Β· Boston, MA Β· Est. 1989 Β· 1001–5000 employees Β· $500M–$1B

HQ: Boston, MA

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology Β· Temple City, California, United States Β· Est. 2011 Β· 1001–5000 employees

HQ: Temple City, California, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

+1 415 483 8800

Novato, California, United States

Legal Name: Ultragenyx Pharmaceutical Inc.
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Founded Date: 2010
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:RARE
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +1 415 483 8800
Last Investment Activity: Feb 26, 2024
Investments Activity: Feb 26, 2024 Jan 9, 2024 Nov 3, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.